BR9508294A - Composto de triazol processo para a preparação dos mesmos composição farmacêutica e utilização de pelo menos um composto - Google Patents

Composto de triazol processo para a preparação dos mesmos composição farmacêutica e utilização de pelo menos um composto

Info

Publication number
BR9508294A
BR9508294A BR9508294A BR9508294A BR9508294A BR 9508294 A BR9508294 A BR 9508294A BR 9508294 A BR9508294 A BR 9508294A BR 9508294 A BR9508294 A BR 9508294A BR 9508294 A BR9508294 A BR 9508294A
Authority
BR
Brazil
Prior art keywords
compound
pct
preparation
pharmaceutical composition
same pharmaceutical
Prior art date
Application number
BR9508294A
Other languages
English (en)
Inventor
Beate Hellendahl
Annegret Lansky
Rainer Munschauer
Siegfried Bialojan
Liliane Unger
Hans-Juergen Teschendorf
Karsten Wicke
Karla Drescher
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6523323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9508294(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9508294A publication Critical patent/BR9508294A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
BR9508294A 1994-07-15 1995-07-14 Composto de triazol processo para a preparação dos mesmos composição farmacêutica e utilização de pelo menos um composto BR9508294A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4425144A DE4425144A1 (de) 1994-07-15 1994-07-15 Triazolverbindungen und deren Verwendung
PCT/EP1995/002781 WO1996002520A1 (de) 1994-07-15 1995-07-14 Triazolverbindungen und deren verwendung als dopamin-d3-liganden

Publications (1)

Publication Number Publication Date
BR9508294A true BR9508294A (pt) 1997-12-30

Family

ID=6523323

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508294A BR9508294A (pt) 1994-07-15 1995-07-14 Composto de triazol processo para a preparação dos mesmos composição farmacêutica e utilização de pelo menos um composto

Country Status (23)

Country Link
US (1) US6124294A (pt)
EP (1) EP0772604B1 (pt)
KR (1) KR100379196B1 (pt)
CN (1) CN1068314C (pt)
AT (1) ATE179703T1 (pt)
AU (1) AU703889B2 (pt)
BG (1) BG63500B1 (pt)
BR (1) BR9508294A (pt)
CA (1) CA2195243C (pt)
CZ (1) CZ292625B6 (pt)
DE (2) DE4425144A1 (pt)
DK (1) DK0772604T3 (pt)
ES (1) ES2131842T3 (pt)
FI (1) FI970147A (pt)
GR (1) GR3030371T3 (pt)
HU (1) HU225961B1 (pt)
IL (1) IL114598A (pt)
NO (1) NO315320B1 (pt)
NZ (1) NZ290387A (pt)
RU (1) RU2167869C2 (pt)
SI (1) SI9520083A (pt)
WO (1) WO1996002520A1 (pt)
ZA (1) ZA955867B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600934A1 (de) 1996-01-12 1997-07-17 Basf Ag Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
CN1329609A (zh) 1998-10-08 2002-01-02 史密丝克莱恩比彻姆有限公司 用作多巴胺d3受体调制剂(精神抑制药)的四氢苯并氮杂䓬衍生物
AR022229A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
JP2003510359A (ja) 1999-10-01 2003-03-18 スミスクライン・ビーチャム・コーポレイション 化合物および方法
ATE402704T1 (de) * 2000-03-27 2008-08-15 Abbott Gmbh & Co Kg Dopamin-d3-rezeptor-liganden zur behandlung von sucht
DE10109867A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
CA2498936C (en) 2002-09-14 2013-02-12 Gov't Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Structurally rigid dopamine d3 receptor selective ligands and process for making them
CZ300500B6 (cs) * 2002-11-11 2009-06-03 Zpusob uzavírání špic v pletacím stroji
DE10304870A1 (de) * 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
US6919342B2 (en) 2003-06-05 2005-07-19 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
TW200510395A (en) * 2003-06-05 2005-03-16 Abbott Gmbh & Co Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
DE10358004A1 (de) 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
EP1694334B1 (en) 2003-12-18 2011-10-19 Abbott GmbH & Co. KG Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
US20050137186A1 (en) 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
EP1778684B1 (en) * 2004-08-09 2009-12-16 Abbott GmbH & Co. KG 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR
KR20070106989A (ko) 2004-12-02 2007-11-06 애보트 게엠베하 운트 콤파니 카게 도파민 ｄ₃ 수용체의 조정에 반응하는 장애의 치료에적합한 트리아졸 화합물
GB0507680D0 (en) 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
CA2694621C (en) 2007-08-07 2015-01-06 Prosarix Limited Novel serotonergic modulators
PA8802101A1 (es) 2007-11-02 2009-08-26 Abbott Gmbh & Co Kg Compuestos de 1,2,4-3,5-diona adecuados para el tratamiento de trastornos que responden a la modulación del receptor de dopamina d3
PT2298747T (pt) * 2008-07-03 2017-02-06 Astellas Pharma Inc Derivado de triazole ou um seu sal

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053085A (pt) * 1964-03-26
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4408049A (en) * 1980-09-17 1983-10-04 The Upjohn Company Substituted piperazinyl-1,2,4-triazoles
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4577020A (en) * 1983-01-25 1986-03-18 The Upjohn Company Aminoalkyl and aminoalkenyl triazoles as anti-psychotic agents
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
FR2580648B1 (fr) * 1985-04-17 1987-05-15 Adir Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2601952B1 (fr) * 1986-07-23 1988-11-25 Carpibem Nouveaux derives amino alkyl thio de triazolopyridine ou triazoloquinoline, leurs procedes de preparation, medicaments les contenant, utiles notamment comme antalgiques
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones

Also Published As

Publication number Publication date
CZ9797A3 (en) 1997-08-13
HU225961B1 (en) 2008-01-28
DE4425144A1 (de) 1996-01-18
DK0772604T3 (da) 1999-11-01
IL114598A (en) 1999-12-22
CN1152919A (zh) 1997-06-25
ZA955867B (en) 1997-01-14
FI970147A0 (fi) 1997-01-14
US6124294A (en) 2000-09-26
KR970704710A (ko) 1997-09-06
EP0772604B1 (de) 1999-05-06
HU9700109D0 (en) 1997-02-28
CA2195243C (en) 2006-05-30
NZ290387A (en) 1999-02-25
ATE179703T1 (de) 1999-05-15
KR100379196B1 (ko) 2003-06-11
BG101113A (en) 1998-04-30
SI9520083A (en) 1997-10-31
FI970147A (fi) 1997-01-14
CA2195243A1 (en) 1996-02-01
EP0772604A1 (de) 1997-05-14
RU2167869C2 (ru) 2001-05-27
NO315320B1 (no) 2003-08-18
JP4114950B2 (ja) 2008-07-09
DE59505853D1 (de) 1999-06-10
CN1068314C (zh) 2001-07-11
WO1996002520A1 (de) 1996-02-01
ES2131842T3 (es) 1999-08-01
NO970161D0 (no) 1997-01-14
CZ292625B6 (cs) 2003-11-12
JPH10502914A (ja) 1998-03-17
AU3111395A (en) 1996-02-16
HUT77128A (hu) 1998-03-02
IL114598A0 (en) 1995-11-27
GR3030371T3 (en) 1999-09-30
BG63500B1 (bg) 2002-03-29
NO970161L (no) 1997-03-14
AU703889B2 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
BR9508294A (pt) Composto de triazol processo para a preparação dos mesmos composição farmacêutica e utilização de pelo menos um composto
BR9508295A (pt) Utilização de compostos de tiazol e tiadiazol composto composição farmacêutica e processos para preparar um composto e tratar distúrbios que respondem a ligantes de receptor d3 de dopamina
FI970148A (fi) Heterosyklisten yhdisteiden käyttö dopamiini-D3-ligandeina
BR9810984A (pt) Composto de triazol, uso do mesmo, e, composição farmacêutica
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
BR9406362A (pt) Composto,processo para a preparação do mesmo e composição anti-nuclear
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto

Legal Events

Date Code Title Description
FA Application withdrawn